An arrayed genome‐wide perturbation screen identifies the ribonucleoprotein Hnrnpk as rate‐limiting for prion propagation

Abstract

A defining characteristic of mammalian prions is their capacity for self-sustained propagation.Theoretical considerations and experimental evidence suggest that prion propagation is modulated by cell-autonomous and non-autonomous modifiers. Using a novel quantitative phospholipase protection assay (QUIPPER) for high-throughput prion measurements, we performed an arrayed genome-wide RNA interference (RNAi) screen aimed at detecting modifiers of prion propagation. We exposed prioninfected cells in high-density microplates to 35'364 ternary pools of 52'746 siRNAs targeting 17'582 genes representing the mouse protein-coding transcriptome. We identified 1191 modulators of prion propagation. While 1151 of these modified the expression of both the pathological prion protein, PrP Sc , and its cellular counterpart PrP C , 40 genes affected selectively PrP Sc . Of the latter, 20 genes augmented prion production when suppressed. A prominent limiter of prion propagation was the heterogeneous nuclear ribonucleoprotein Hnrnpk. Psammaplysene A (PSA), which binds Hnrnpk, reduced prion levels in cultured cells and protected them from cytotoxicity. PSA also reduced prion levels in infected cerebellar organotypic slices and alleviated locomotor deficits in prion-infected Drosophila melanogaster expressing ovine PrP C . Hence, genome-wide QUIPPER-based perturbations can discover actionable cellular pathways involved in prion propagation. Finally, the unexpected identification of a prioncontrolling ribonucleoprotein suggests a role for RNA in the generation of infectious prions..

Advancing surgical instrument safety: A screen of oxidative and alkaline prion decontaminants using real-time quaking-induced conversion with prion-coated steel beads as surgical instrument mimetic

“…However, the efficacy of prion inactivation procedures tested on rodent prions cannot be completely generalized to human prions [ 54 , 64 , 65 ]. In the future, however, SAAs such as TESSA, that are applicable to many different prion strains [ 9 , 66 , 67 ], could be used as animal-free methods for the additional validation of prion decontaminants on multiple prion strains.…”

A screen of alkaline and oxidative formulations for their inactivation efficacy of metal surface adsorbed prions using a steel-bead seed amplification assay

“…However, the efficacy of prion inactivation procedures tested on rodent prions cannot be completely generalized to human prions (Adjou, Demaimay et al 1996, Kawasaki, Kawagoe et al 2007, Bélondrade, Jas-Duval et al 2020). In the future, however, SAAs such as TESSA, that are applicable to many different prion strains (Hughson, Race et al 2016, Cooper, Hoover et al 2019, Avar, Heinzer et al 2022, could be used as animal-free methods for the additional validation of prion decontaminants on multiple prion strains.…”

A model of human neural networks reveals NPTX2 pathology in ALS and FTLD

“…To generate shRNA-expressing vectors, our previously build pSHE lentivirus transfer vector 64 was modified using Q5 site directed mutagenesis kit (NEB E0554S; Q5 kit) to substitute the shRNA sequence for either NPTX2 or TARDBP- targeting shRNAs (see Supplementary Table 11 for primer sequences) and using NEBuilder HiFi DNA Assembly Cloning Kit (NEB E5520; HiFi kit) to substitute the EGFP sequence with either TDP-43–HA (resulting in pshTDP vectors (used in NPTX2 rescue experiments) carrying hU6-driven NPTX2 (or NT controls) shRNA and inducible mTRE-TDP-43–HA) or HaloTag (resulting in psHalo vectors (used in TDP-43-knockdown experiments) carrying hU6-driven TARDBP shRNA and inducible mTRE-HaloTag). Similarly, pshTDP vectors for dual luminescence experiments were generated so that they carry hU6-driven endo- TARDBP shRNA (or NT control) and inducible mTRE-TDP-43–HA (with or without mutations in the RNA-recognition motif; shRNA-resistant (exploiting silent mutations present in our TDP-43–HA construct)).…”